These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 475853)
1. Differences in benzo(a)pyrene metabolic profile in rat and mouse ovary. Mattison DR; West DM; Menard RH Biochem Pharmacol; 1979 Jul; 28(13):2101-4. PubMed ID: 475853 [No Abstract] [Full Text] [Related]
2. Genetic differences in mouse ovarian metabolism of benzo [a]pyrene and oocyte toxicity. Mattison DR; Thorgeirsson SS Biochem Pharmacol; 1977 May; 26(9):909-12. PubMed ID: 861061 [No Abstract] [Full Text] [Related]
3. The fate of intratracheally installed benzo(a)pyrene in the isolated perfused rat lung of both control and 20-methylcholanthrene pretreated rats. Vainio H; Uotila P; Hartiala J; Pelkonen O Res Commun Chem Pathol Pharmacol; 1976 Feb; 13(2):259-71. PubMed ID: 1257613 [TBL] [Abstract][Full Text] [Related]
4. Kinetic determinants of benzo[a]pyrene metabolism to dihydrodiol epoxides by 3-methylcholanthrene-induced rat liver microsomes. Keller GM; Turner CR; Jefcoate CR Mol Pharmacol; 1982 Sep; 22(2):451-8. PubMed ID: 6292697 [No Abstract] [Full Text] [Related]
5. A comparison of benzo(a)pyrene metabolism by liver and lung microsomal enzymes from 3-methylcholanthrene-treated rhesus monkeys and rats. Hundley SG; Freudenthal RI Cancer Res; 1977 Sep; 37(9):3120-5. PubMed ID: 406987 [No Abstract] [Full Text] [Related]
6. Influence of inducers and inhibitors of mixed-function oxidasts on benzo(a)pyrene binding to the DNA of rat liver nuclei. Alexandrov K; Thompson MH Cancer Res; 1977 May; 37(5):1443-9. PubMed ID: 856463 [TBL] [Abstract][Full Text] [Related]
7. Effects of phenobarbital, 3-methylcholanthrene and beta-naphthoflavone pretreatment on mouse liver microsomal enzymes and on metabolite patterns of benzo[a]pyrene. Wang IY Biochem Pharmacol; 1981 Jun; 30(11):1337-43. PubMed ID: 6268094 [No Abstract] [Full Text] [Related]
8. Specificity of chemiluminescence in the metabolism of benzo[a]pyrene to its carcinogenic diol epoxide. Hamman JP; Seliger HH; Posner GH Proc Natl Acad Sci U S A; 1981 Feb; 78(2):940-2. PubMed ID: 6785756 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of benzo(a)pyrene and benzo(a)pyrene 7,8-dihydrodiol metabolism by benzo(a)pyrene quinones. Shen AL; Fahl WE; Wrighton SA; Jefcoate CR Cancer Res; 1979 Oct; 39(10):4123-9. PubMed ID: 113086 [No Abstract] [Full Text] [Related]
10. Fluorescence study of DNA-binding metabolites of benzo(a)pyrene formed in hepatocytes isolated from 3-methylcholanthrene-treated rats. Jernström B; Orrenius S; Undeman O; Gräslund A; Ehrenberg A Cancer Res; 1978 Aug; 38(8):2600-7. PubMed ID: 667854 [TBL] [Abstract][Full Text] [Related]
11. Specific quenching of the fluorescence of benzo (a) pyrene by hepatic microsomes from 3-methylcholanthrene-treated rats. Matsuyama A; Kaneko M; Nagata C Biochem Biophys Res Commun; 1977 Aug; 77(3):918-24. PubMed ID: 901521 [No Abstract] [Full Text] [Related]
12. Covalent binding of benzo[a]pyrene to rat liver cytosolic proteins and its effect on the binding to microsomal proteins. Schelin C; Tunek A; Jergil B Biochem Pharmacol; 1983 May; 32(9):1501-6. PubMed ID: 6305370 [TBL] [Abstract][Full Text] [Related]
13. Protection against toxic redox cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono- and diglucuronide. Lilienblum W; Bock-Hennig BS; Bock KW Mol Pharmacol; 1985 Apr; 27(4):451-8. PubMed ID: 3982390 [TBL] [Abstract][Full Text] [Related]
14. Inhibition by 17-alpha-ethinyl estradiol of benzo[a]-pyrene metabolism in isolated adult rat hepatocytes. Benrekassa J; Decloitre F Biochem Pharmacol; 1983 Jan; 32(2):347-53. PubMed ID: 6307317 [No Abstract] [Full Text] [Related]
15. Comparative metabolism of Benzo(a)pyrene in some rodents. Husain MM; Dehnen W; Monch W Toxicol Eur Res; 1978 Mar; 1(2):75-83. PubMed ID: 741473 [No Abstract] [Full Text] [Related]
16. Different patterns of benzo[a]pyrene metabolism of purified cytochromes P-450 from methylcholanthrene, beta-naphthoflavone and phenobarbital treated rats. Gozukara EM; Guengerich FP; Miller H; Gelboin HV Carcinogenesis; 1982; 3(2):129-33. PubMed ID: 6279326 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of benzo(a)pyrene and (-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene by rat liver nuclei and microsomes. Pezzuto JM; Yang CS; Yang SK; McCourt DW; Gelboin HV Cancer Res; 1978 May; 38(5):1241-5. PubMed ID: 639057 [No Abstract] [Full Text] [Related]
18. Oxidation and subsequent glucuronidation of 3,4-benzopyrene in everted intestinal sacs in control and 3-methylcholanthrene-pretreated rats. Hietanem E Pharmacology; 1980; 21(4):233-43. PubMed ID: 6252563 [TBL] [Abstract][Full Text] [Related]
19. Roles of UDP-glucuronosyltransferase in the inactivation of benzo(a)pyrene. Bock KW; Bock-Hennig BS; Lilienblum W; Pfeil H; Volp RF Adv Exp Med Biol; 1981; 136 Pt A():53-73. PubMed ID: 6283814 [No Abstract] [Full Text] [Related]
20. Differences in benzo(a)pyrene metabolism between rodent liver microsomes and embryonic cells. Selkirk JK; Croy RG; Wiebel FJ; Gelboin HV Cancer Res; 1976 Dec; 36(12):4476-9. PubMed ID: 1000495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]